LabCentral Houses Scientific Visionaries
Engaged in Early-Stage Research


EdiGENE Corporation is an emerging biotech company focusing on developing transformative therapeutics for unmet medical needs using its proprietary technologies on CRISPR and protein engineering platforms. The company has a strong foundation on intellectual property licensed from the University of Tokyo.

  • Haru Morita President & CEO, Board of Directors
  • Tetsuya Yamagata, MD, Ph.D Vice President, Research